| 证券代码 | INNTW.O |
| 证券名称 | Innovate Biopharmaceuticals Inc Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2016-07-08 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | 9 Meters Biopharma, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 8480 Honeycutt Road, Suite 120, Raleigh, North Carolina, USA |
| 成立日期 | 2012 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.9meters.com |
| 电话 | +1 (919) 275-1933 |
| 传真 | - |
| 公司简介 | 9 Meters Biopharma, Inc. is a publicly traded clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases with unmet needs. The pipeline includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis. Innovate is led by a strong management team with extensive drug development experience and a history of bringing novel therapeutics to market. All global rights to the products, which are backed by more than 150 patents worldwide, are owned by the company. |